$1.95
-0.24-10.96%
Últ. Act.: Nov 6, 7:12 PM
Cardlytics (CDLX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-1.03 | $-1.04 | 0.96 % |
| Q2 | Aug 5, 2026 | $-0.81 | $-1.35 | 40.0 % |
| Q1 | May 7, 2026 | $-1.10 | $-2.40 | 54.2 % |
| Q4 | Mar 4, 2026 | $0.30 | $-1.50 | 120.0 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $32.88M | $37.07M | -11.3 % |
| Q2 | Aug 5, 2026 | $36.88M | $37.00M | -0.33 % |
| Q1 | May 7, 2026 | $34.32M | $37.10M | -7.50 % |
| Q4 | Mar 4, 2026 | $56.10M | $54.46M | 3.01 % |
Cardlytics (CDLX) publicó su última previsión de noviembre 5, 2026 para Q4 2026. La compañía estimó ingresos en un rango de $35M - $39M para el período.
En comparación con la previsión anterior, Cardlytics elevado redujo su previsión de ingresos desde un rango anterior de $34M - $39M.
Cardlytics ha emitido 18 actualizaciones de orientación entre el marzo 1, 2023 y el noviembre 5, 2026. During this period, the company raised its outlook 10 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.04 | $-1.35 | $-2.40 | $-1.50 |
| Actual | $-1.03 | $-0.81 | $-1.10 | $0.30 |
| Surprise | +0.96% | +40.0% | +54.2% | +120.0% |
| Revenue | ||||
| Estimate | $37.1M | $37.0M | $37.1M | $54.5M |
| Actual | $32.9M | $36.9M | $34.3M | $56.1M |
| Surprise | -11.3% | -0.33% | -7.50% | +3.01% |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.84 | $-1.39 |
| Revenue | ||
| Consensus | $41.2M | $34.4M |